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Abstract
Fuchs endothelial corneal dystrophy (FECD) is a common, late-onset disorder of the corneal endothelium. Although
progress has been made in understanding the genetic basis of FECD by studying large families in which the phenotype is
transmitted in an autosomal dominant fashion, a recently reported genome-wide association study identified common
alleles at a locus on chromosome 18 near TCF4 which confer susceptibility to FECD. Here, we report the findings of our
independent validation study for TCF4 using the largest FECD dataset to date (450 FECD cases and 340 normal controls).
Logistic regression with sex as a covariate was performed for three genetic models: dominant (DOM), additive (ADD), and
recessive (REC). We found significant association with rs613872, the target marker reported by Baratz et al.(2010), for all
three genetic models (DOM: P=9.33610
235; ADD: P=7.48610
230; REC: P=5.27610
26). To strengthen the association study,
we also conducted a genome-wide linkage scan on 64 multiplex families, composed primarily of affected sibling pairs
(ASPs), using both parametric and non-parametric two-point and multipoint analyses. The most significant linkage region
localizes to chromosome 18 from 69.94cM to 85.29cM, with a peak multipoint HLOD=2.5 at rs1145315 (75.58cM) under the
DOM model, mapping 1.5 Mb proximal to rs613872. In summary, our study presents evidence to support the role of the
intronic TCF4 single nucleotide polymorphism rs613872 in late-onset FECD through both association and linkage studies.
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Introduction
Fuchs endothelial corneal dystrophy (FECD), first described by
Ernst Fuchs [1], is a common progressive disorder of the corneal
endothelium that typically becomes symptomatic during the fifth
or sixth decade of life [2,3], although corneal endothelial
abnormalities can be clinically detected several years before
patients become symptomatic [4]. The disorder affects as much as
4% of the United States population over the age of 40 years [5–7]
and occurs predominantly in women, who comprise approximate-
ly 75% of cases [8]. This debilitating disorder leads to corneal
edema with a loss of corneal clarity, painful episodes of recurrent
corneal erosions, severe impairment of visual acuity, and
sometimes even blindness.
FECD is often inherited as an autosomal dominant trait [5,9–
13] and 50% of clinical cases of FECD are estimated to show
familial clustering [2]. While it is recognized that FECD has a
genetic basis, few genes have been identified that explain the
genetic underpinnings of FECD susceptibility. The first gene to be
causally linked with FECD was COL8A2 (MIM: 120252) on
chromosome 1, in which two missense mutations, p.L450W and
p.Q455V/Q455K, have been replicated in rare early-onset
(before 40 years of age) FECD multigenerational families [3,13–
15] and in atypical sporadic FECD cases [15]. Additional COL8A2
missense mutations have been identified in late-onset FECD
patients, although their role remains unclear due to conflicting
results [16–18]. Mutations in two additional genes that play roles
in other corneal endothelial dystrophies have also been suggested
to cause FECD. SLC4A11 (MIM: 610206), which causes
autosomal recessive congenital hereditary endothelial dystrophy
(CHED2, MIM: 217700) [19], was found to contain mutations in
Chinese, Indian, and Caucasian patients with the common late-
onset phenotype of FECD [20,21]. Additionally, mutations in
TCF8 (MIM: 609141), whose loss of function causes posterior
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were recently reported in late-onset Caucasian [23] but not in
Chinese FECD patients [24].
Several genome-wide linkage scans using large multigenera-
tional families have reported FECD loci on chromosomes 13
(FCD1), 18 (FCD2), 5 (FCD3), and 9 (FCD4) [23,25–27]. Our own
genome-wide linkage scan using affected sibpairs (ASPs) from 21
late-onset FECD families and one large multigenerational family
[28] detected five regions of linkage with multipoint LOD scores
.1.5, including the chromosome 1p region near COL8A2. Neither
our late-onset FECD families nor our large, multigenerational
family replicated the four previous FECD loci (FCD1 to FCD4), but
the number of families used in the study may have been
underpowered to detect significant linkage.
The first genome-wide association study (GWAS) for FECD was
reported recently, using an initial dataset of 130 unrelated cases
and 260 unaffected controls genotyped with the Illumina 370K
BeadChip panel [29]. After genotyping their most significant
findings in a replication dataset containing 150 cases and 150
controls, Baratz and colleagues concluded that a single nucleotide
polymorphism (SNP) on chromosome 18q21, rs613872, in an
intron of a gene encoding transcription factor 4 (TCF4, MIM:
602272) showed genome-wide significant association with FECD
(P=1.10x10
212 for the initial GWAS dataset; P=1.79x10
213 for
the replication dataset; P=2.34x10
226 for the combined dataset).
Here we present additional evidence for the presence of a
FECD locus on chromosome 18. We report the results from an
expansion of our previous linkage study, as well as an association
study analyzing the association of rs613872 with FECD in a
dataset containing 450 unrelated FECD cases and 340 unaffected
controls, the largest sample of FECD patients interrogated to date.
Materials and Methods
Ethics Statement
Our study was performed in accordance with the Declaration of
Helsinki and the institutional review boards at Duke University
Medical Center and Johns Hopkins University (JHU) specifically
approved this study. Both FECD study sites, the Cornea Clinics at
Duke University Eye Center (DUEC) and the Wilmer Eye
Institute at JHU, obtained the appropriate institutional review
board approval for research on human subjects prior to initiating
subject recruitment, and all individuals gave written, informed
consent. The control subjects from the Duke glaucoma genetics
study were also recruited under the approval of the Duke
Institutional Review Board, and consented to allow their biological
samples to be used by other research studies.
Subjects and Families
All FECD subjects underwent detailed ophthalmic examination,
including slit lamp biomicroscopy, to determine FECD severity.
Grading of disease severity was determined using a slightly
modified version of the Krachmer scale classification system [2],
which classifies severity on a scale of 0 to 5: (1) grade 0: no central
cornea guttae; (2) grade 1: scattered central cornea guttae; (3)
grade 2: 1 or 2 mm of central cornea guttae; (4) grade 3: 2 to
5 mm of grouped cornea guttae; (5) grade 4: .5 mm of grouped
central cornea guttae; (6) grade 5: cornea guttae with corneal
edema. Subjects were classified as affected if grade $2, unaffected
if the corneal examination was normal (grade =0), and unknown
if grade 1.
Two Caucasian datasets were used for association and linkage
studies. The association dataset consisted of 450 unrelated FECD
cases, each with a Krachmer grade $2, and 340 unaffected
controls with age at enrollment of $45 years old. The 450
unrelated cases used here were either probands from the family
dataset (see below) or singleton cases, all of whom were ascertained
through the cornea clinic at DUEC. The unrelated controls were
from 26 unaffected married-in spouses from the DUEC family
dataset and 314 control subjects from the glaucoma genetic study
at DUEC [30]. Glaucoma control subjects underwent detailed eye
examination and had no signs of corneal abnormalities at the time
of subject enrollment.
The linkage dataset consisted of 64 multiplex families (at least
two affected individuals per family) containing a total of 215
subjects (69.8% females). Families were ascertained independently
from the Cornea Clinics at DUEC or at the Wilmer Eye Institute
at JHU. Demographic data, including age at enrollment and
gender, for the individuals analyzed in the association and linkage
datasets are summarized in Table 1.
Marker Selection and Genotyping
Association analysis focused on the SNP rs613872 in TFC4, the
most significantly associated SNP in the GWAS performed by
Baratz and colleagues [29]. We also genotyped rs10490775 in
PTPRG on chromosome 3, which was significant but not at a
genome-wide level in the Baratz GWAS, to examine possible
replication in our dataset. The two SNPs were genotyped with pre-
designed TaqManH allelic discrimination assays (Life Technolo-
gies, formerly Applied Biosystems, Inc., Foster City, CA), which
use unlabeled polymerase chain reaction (PCR) primers and two
allele-specific probes containing the TaqManH minor groove
binding group (MGB) probe and either a FAM
TM and VICH dye
label in a 384-well plate format. PCR reactions were performed
with TaqmanH Universal PCR Master Mix on the GeneAmpH
PCR System 9700 (Applied Biosystems, Inc.), and the ABI
7900HT Fast PCR System (Applied Biosystems, Inc.) was used for
reading allelic discrimination calls. Quality control (QC) samples,
including two CEPH (Centre d’Etude du Polymorphisme
Humain) pedigree individuals, one no-template sample, and two
duplicate samples (one male, one female), were contained within
each quadrant of each 384-well plate. These QC samples were
used to provide duplicate samples within one quadrant, across
quadrants within one plate, and across plates. Results of the
CEPH and QC sample genotyping were compared to identify
possible sample plating errors and genotype-calling inconsisten-
Table 1. Demographic data for individuals analyzed in the
linkage and association datasets.
Dataset Variable Summary
Linkage No. of families (DUEC, JHU)
a 64 (40, 24)
No. of samples (No. of affected) 215 (165)
No. of ASPs
b 81
Male, Female 65, 150
Mean (SD
c)o fa g e
d in years 62.47 (13.6)
Association No. of samples (affected, unaffected) 790 (450, 340)
Male, Female 280, 510
Mean (SD) of age in years 66.8 (10.9)
aDUEC: Duke University Eye Center; JHU, Johns Hopkins University.
bASPs: affected sibpairs (ASP) count is based on n-1 for n siblings per family
cSD:
standard deviation.
dAge: age at the time of study enrollment.
doi:10.1371/journal.pone.0018044.t001
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efficiency was required for submission to the analysis database.
Two Illumina (San Diego, CA) SNP linkage panels were used
for genome-wide linkage marker genotyping. Seventy-two of the
215 linkage samples were included in our previous linkage study
[28], and were genotyped using the Illumina GoldenGate linkage
panel IVB, which contains 5,858 SNPs. The remaining 143
samples were genotyped using the Illumina Infinium HumanLink-
age-12 platform containing 6,090 SNPs, of which 4,811 overlap
with the GoldenGate IVB platform. All genomic DNA samples
were prepared at a concentration of 75 ng/mL, in a total volume
of 10 mL, and were genotyped in four multiplexed assays
according to the manufacturer’s protocols. All DNA samples were
extracted from blood using the PureGene system (Gentra Systems,
Minneapolis, MN).
Data cleaning for the association dataset
Reproducibility of genotypes was examined for the replicate
QC samples located in each 384-well Taqman plate to assess
genotyping quality. Reproducibility rates of 100% were observed.
The two SNP markers, rs613872 and rs10490775, were examined
for possible deviations from Hardy-Weinberg equilibrium (HWE).
Data cleaning for the linkage dataset
We instituted several QC measures to determine the final set of
markers for analysis. We first used the Illumina BeadStudio
program to check genotype reproducibility rates using the
replicated samples, family relationships, gender status of each
DNA sample using Y chromosome markers, sample genotype call
rates .99%, and the GenCall score which is a quality measure for
each genotype used in the Illumina genotyping system. In
particular, the GenCall score measures how close a genotype is
to the center of the cluster of other samples assigned the same
genotype, as compared with the centers of the clusters of the other
genotypes, and ranges from 0 to 1. The higher the GenCall score
the more reliable the genotype. A set of clean markers was chosen
based on GenCall scores $0.15, as well as meeting the other QC
measures described previously, for further data cleaning.
For additional data quality assurance, 1000 markers with
approximately equal inter-marker distances across the genome
were selected to examine family relationships using the RELPAIR
[31] and PREST [32] programs. After correcting for family
relationship errors, Mendelian inheritance inconsistencies were
checked using the PEDCHECK program [33]. Missing genotypes
were assigned to the family for those markers with Mendelian
inheritance inconsistencies.
All SNPs were tested for deviations from HWE. We randomly
chose one affected individual per family to include in an unrelated
affected dataset, and one unaffected individual per family was
selected to include in an unrelated, unaffected dataset. An exact
test implemented in the Genetic Data Analysis (GDA) program
was used to test HWE, by performing 3,200 permutations to
estimate the empirical p-value for each marker [34]. We applied a
Bonferroni correction (significance threshold =0.05/total number
of markers) to determine significant deviation from HWE. Markers
that were out of HWE in the unaffected dataset were excluded in
the linkage analysis.
Association Analysis
Genotypes of rs613872 (T and G nucleotide polymorphism)
were tested using three genetic models: dominant (DOM), additive
(ADD), and recessive (REC). The genotypes of (GG, TG, and TT)
were coded as (1, 1, 0) for DOM; (2, 1, 0) for ADD; and (1, 0, 0) for
REC where allele G is the rare allele. A logistic regression
association analysis in PLINK [35] was applied with gender as a
covariate. We also stratified our association dataset by gender and
tested for association of this marker within the males and females.
A nominal significance level of 0.05 was applied to declare
significant association. The relationship between disease severity
(grade level) and genotypes of rs613872 was examined using Fisher
Exact test, because some genotype-phenotype has small number of
samples, particularly for grade 4.
Linkage analysis
Two-point parametric linkage analyses using the FASTLINK
[36] and HOMOG [37] programs (http://linkage.rockefeller.
edu/, provided in the public domain by Rockefeller University,
New York, NY) were performed to generate heterogeneity
logarithm of the odds (HLOD) scores. Since the mode of
inheritance is unknown for FECD, both DOM and REC genetic
models were assumed in the parametric analysis with disease allele
frequencies of 0.001 and 0.01 respectively. The penetrance
(chance of an individual being affected if carrying the disease
susceptibility genotype) was based on the assumed genetic models,
and was consistent with the goal of conducting an affecteds-only
parametric linkage analysis.
MERLIN [38] was used to perform both multipoint parametric
and non-parametric linkage analyses (NPL). The same DOM and
REC models described above were assumed in the MERLIN
parametric analysis. It is known that linkage disequilibrium (LD)
may inflate the type I error of a multipoint linkage analysis,
particularly when parental genotype data are not available—as is
the case for most of our families [39]. We set a threshold of the
squared Pearson correlation coefficient (r
2) between markers at
0.16 in MERLIN to ensure independence between markers for
multipoint linkage analysis.
Results
Association results
We tested rs613872 in our case-control association dataset of
450 cases and 340 controls; Table 1 summarizes the demographic
data of our subjects. We did not observe deviation from HWE in
the control group for rs613872 (P=0.60), indicating high quality
genotyping results. However, we found strong deviation from
HWE for this marker in the FECD case group (P,0.001). This
may be the source of the highly significant association signal we
observed in our dataset for all three genetic models (DOM:
P=9.33610
235; ADD: P=7.48610
230; REC: P=5.27610
26).
The effect size of the minor (risk) allele (G) in our dataset was
strong: (1) DOM: odds ratio (OR)=8.01, confidence interval (CI)
of OR=(5.80; 11.29); (2) ADD model: OR=5.35, CI= (4.00;
7.14); (3) REC: OR=4.06, CI= (2.22; 7.42). These results are
consistent with the findings of Baratz and colleagues [29]. Table 2
shows the comparison of genotype frequencies between our FECD
cases and controls to the genotype frequencies observed in the
FECD GWAS cases and controls studied by Baratz and
colleagues. Clearly, the FECD case group has excessive hetero-
zygous genotypes for rs613872 compared to the controls in both
datasets, which is consistent to the observation of deviation from
HWE in FECD cases. As for rs10490775 in PTPRG on
chromosome 3, we did not detect significant association with
FECD (DOM P=0.98; ADD P=0.96; REC P=0.92).
When we examined gender-specific groups, we observed the
same elevation of the heterozygous (GT) genotype in cases relative
to controls in both genders (Table 2). The SNP rs613872 is still
significant in both genders (male P=3 610
226; female
P=1.2610
216). However, this result may not reflect the true
Replication of TCF4 Locus in FECD
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males. Furthermore, the results between genders should not be
compared due to the unbalanced sample sizes. Among our 450
cases, we have 235 cases with grading information. We did not
find the correlation between disease severity and genotypes of
rs613872 (P=0.13). However, more samples may be needed to
make a solid conclusion.
Linkage scan samples and markers
After implementing QC measures for the linkage dataset we
removed five individuals from three families due to relationship
errors that could not be resolved and five individuals due to
low sample call rates (,95%). In total, we analyzed 215
individuals in 64 families (Table 1), including 41 ASPs from
64 families, making this the largest dataset used in a genome-
wide linkage scan for FECD to date. We noted a high
proportion of females in both our linkage and association
datasets, likely because of the known gender imbalance among
FECD patients [8].
A total of 7,291 markers were genotyped between the two SNP
genotyping platforms, with 4,551 markers overlapping between
the two chips. Of those, 4,533 markers met our QC criteria for
linkage analyses, which included having a GenCall score $0.15, a
genotype call frequency $95%, and no significant deviation from
HWE. Eleven markers produced Mendelian inheritance inconsis-
tencies within three families and were assigned missing genotypes
within those families. In the multipoint analysis using MERLIN,
3,927 markers met our LD criteria and were analyzed.
Linkage regions
Eighteen SNPs on ten chromosomes gave two-point HLOD
scores $2 in either the DOM or REC models (Table 3). In
particular, three markers produced HLOD scores above 3:
rs1889974 (chromosome 10, 119.34 cM, HLOD=3.37) and
Table 2. Comparison of genotype frequencies between Duke dataset and dataset used in Baratz et al. (2010), and between male
and female in Duke dataset for rs613872.
Duke dataset Baratz et al. Duke dataset Male Duke dataset Female
Case Control Case Control Case Control Case Control
Genotype N
*=450 N=340 N=280 N=410 N=123 N=153 N=322 N=182
GG 0.15 0.04 0.1 0.02 0.18 0.03 0.14 0.05
GT 0.66
** 0.3 0.61 0.25 0.72 0.27 0.63 0.33
TT 0.2 0.66 0.29 0.73 0.10 0.70 0.23 0.62
*N: total sample size.
**Heterozygous frequencies are elevated in all datasets and are highlighted in bold.
doi:10.1371/journal.pone.0018044.t002
Table 3. Markers with HLOD .2 in either dominant (DOM) or recessive (REC) model from the FASTLINK/HOMOG two-point linkage
analysis.
Chromosome SNP marker deCODE map (cM) DOM HLOD score REC HLOD score
1 rs726344 52.86 1.57 2.20
1 rs491603 56.95 1.64 2.54
5 rs476569 64.08 1.64 2.02
5 rs1301475 78.25 2.22 0.61
5 rs998876 194.22 2.00 1.59
8 rs2466216 40.75 2.65 0.51
8 rs9797 46.84 2.06 1.37
8 rs1380229 88.89 2.26 0.41
9 rs1407392 113.18 1.14 2.62
9 rs1923433 113.20 1.86 2.34
10 rs1889974 119.34 3.37 1.83
15 rs235512 61.47 3.53 1.84
18 rs4941043 78.82 1.99 3.00
19 rs7937 66.65 0.80 2.19
19 rs893186 110.25 1.30 3.56
20 rs674630 30.36 2.17 1.41
X rs1207480 73.97 1.46 2.70
X rs1990383 166.56 2.08 0.07
Abbreviation: SNP, single nucleotide polymorphism; cM, centiMorgans; HLOD, heterogeneity logarithm of the odds.
doi:10.1371/journal.pone.0018044.t003
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DOM model and rs893186 (chromosome 19, 110.25 cM,
HLOD=3.56) under the REC model. Among all markers listed
in Table 3, only rs998876 on chromosome 5 (194.22 cM)
overlaps with a previously identified FECD linkage locus, FCD3
[27]. Table 4 summarizes the eight linkage regions that produced
peak multipoint LOD scores $1.5 in any of the three multipoint
linkage analyses, the nonparametric (NPL) and parametric (DOM
and REC) analyses. The boundaries of a linkage region outlined in
Table 4 are based on the chromosomal interval that covers one
LOD score below the peak marker’s LOD score. Two separate
regions of linkage were found on chromosomes 16 (28.27–
36.15 cM and 56.82–96.27 cM) and X (59.18–83.83 cM and
98.35–124.34 cM), implying that multiple genes on the same
chromosome could be influencing FECD.
The most promising multipoint linkage region was on chromo-
some 18 from 69.94 cM to 85.29 cM with a peak multipoint
HLOD=2.5 at rs1145315 (75.58 cM) under the DOM model. The
nonparametric analysisshowedconsistentresultsforthisregionwith
a peak multipoint HLOD=1.48 at the same peak marker
(Table 4). In addition, rs4941043 within this same interval
produced a HLOD score=1.99 under the two-point DOM model
(Table 3). This multipoint linkage peak on chromosome 18
overlaps with the FCD2 peak reported by Sundin et al. [26] and with
the most significant GWAS hit, rs613872 in TCF4, reported by
Baratz et al. [29] (Figure 1). The SNP rs613872 in TCF4 is only
1.4 Mb away from our peak DOM multipoint marker, rs1145315.
Discussion
To date, progress towards identifying the genetic underpinnings
of FECD has been limited to a handful of genes, including
COL8A2, SLC4A11, and TCF8 [3,13,20,21,23] that have arisen
from candidate gene or genome-wide linkage studies. Linkage
scans have additionally identified four genetic loci (FCD1 to FCD4)
that appear to influence familial FECD [23,25–27]. In spite of
these insights, knowledge of the genetic basis of non-familial
FECD has remained limited. Recently, Baratz and colleagues
identified significant statistical association between a SNP in TCF4
and FECD in the first genome-wide association study carried out
for FECD [29]. Their study identified an intronic SNP in TCF4,
rs613872, with highly significant allelic and genotypic p-values of
2.34610
226 and 1.29610
218, respectively, in their combined
analysis of their small discovery and replication datasets.
Here, we present a large case-control association dataset that
replicates these recent genome-wide association data [29], revealing a
highly significant association between rs613872 and FECD with a p-
value of 9.33610
235 (DOM). Additionally, we show that the best
Table 4. Results of the multipoint linkage analysis using MERLIN.
Chr Peak and boundary SNPs deCODE map (cM) NPL (LOD score) DOM (HLOD score) REC (HLOD score)
6 rs1563512 120.96 0.64 0.63 0.00
rs988693 (peak) 127.33 1.29 1.74 0.19
rs1894641 129.27 1.07 1.36 0.28
9 rs4077800 92.50 0.58 0.68 0.37
rs1819730 (peak) 109.99 1.55 1.04 1.16
rs1405 122.92 0.71 0.70 0.02
16 rs887864 28.27 0.25 0.08 1.04
rs734826 (peak) 31.98 0.84 0.39 2.29
rs2384933 36.15 0.73 0.31 1.42
16 rs13143 56.82 0.59 0.14 0.01
rs149156 (peak) 84.70 1.60 1.08 0.19
rs1922604 95.27 0.59 0.41 0.65
18 rs1873191 69.94 0.80 1.05 0.00
rs1145315 (peak) 75.58 1.48 2.50 0.08
rs955427 85.29 0.43 1.50 0.00
19 rs1058511 105.07 0.01 0.00 0.71
rs1542039 (peak) 108.49 0.12 0.00 1.71
rs893179 109.90 0.08 0.00 1.51
X rs2024917 59.18 0.87 0.00 0.68
rs1155699 (peak) 67.14 1.56 0.25 1.37
rs979605 (peak) 67.42 1.56 0.25 1.36
rs1327476 83.83 0.88 0.23 0.05
X rs897918 98.35 0.69 0.24 0.17
rs1558022 (peak) 115.73 1.70 0.56 0.11
rs9856 124.34 0.73 0.85 0.20
Note: All linkage regions with a LOD score .1.5 at the peak marker in at least one of the multipoint analyses, nonparametric (NPL), dominant (DOM), or recessive (REC),
are presented. The upper and lower bounds of each linkage peak interval presented were selected based on covering all markers with a LOD or HLOD score within one
LOD score unit of the peak marker’s LOD score. The peak LOD scores are indicated with bold text. Chr, chromosome; SNP, single nucleotide polymorphism; LOD,
logarithm of the odds; HLOD, heterogeneity logarithm of the odds.
doi:10.1371/journal.pone.0018044.t004
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chromosome 18 (68.94 cM to 85.29 cM), with a peak multipoint
HLOD=2.5 at rs1145315, 1.5 Mb away from rs613872 in TCF4.
The consistent findings in both our linkage and association studies for
an association of rs613872 with FECD together with the findings of
Baratz et al. suggest that the association is probably not spurious but,
rather, is due to certain recombination events in this region that may
increase susceptibility to FECD. Additionally, the excess of heterozy-
gous genotypes at rs613872 in both our cases and those of Baratz et al.
warrants further investigation. Although we replicated the association
of rs613872 with FECD in our dataset, we failed to replicate the
association with rs10490775 in PTPRG. Since we also did not detect
evidence of linkage to chromosome 3, we hypothesize that either this
locus does not influence FECD risk or its effect on FECD risk is small.
It is of great interest to know if rs613872 genotypes can predict
disease severity. Our 235 cases with grading information did not
show significant correlation to the genotypes of rs613872, which is
consistent to the finding from Riazuddin et al. [40], where 180 cases
were used. Although both studies obtained the same observation,
the limited sample sizes are the drawback for making a solid
conclusion. Many of our early samples were given disease status
diagnosis rather than detailed grading information. As our
recruitment of FECD cases moving forward, we will be able to
increase the number of cases with grading. The disease severity vs.
genotypesofanytargetmarkerwill beable tobeevaluatedproperly.
According to data from the Human Genome Diversity Project,
the minor (risk) allele, G, of rs613872 is rare to nonexistent in
populations from Africa, Eastern Asia, and Central and South
America, yet is more frequent in European, Middle Eastern, and
Southern Asian populations (Figure 2, [41]). Given that the
FECD cases analyzed by our group and by Baratz et al. are of
European descent, it will be important to examine whether the
association between rs613872 and FECD risk replicates in other
ethnic and racial populations. It is possible that alternative TCF4
risk alleles may be associated in other ethnic and racial
populations, which would argue for this locus being functionally
important in FECD pathogenesis. Alternatively, if the true FECD
disease variant is in LD with rs613872, a lack of association in
other ethnic and racial populations may help explain why the
disorder has a lower prevalence in other populations like African,
East Asian, and South American populations.
GWAS studies commonly raise the question of how to interpret
the biological significance of statistically associated SNPs, which
may be located in intronic or intergenic regions with no obvious
connection to the disease phenotype. Baratz and colleagues did
not find any coding variations within the TCF4 gene that might
help explain the functional mechanism behind the association of
rs613872 with FECD, so clearly further studies are needed to
detect such variations if they exist. Although TCF4 is an attractive
candidate gene within the FCD2 locus, much remains unknown. If
TCF4 plays a role in familial FECD, further research is needed
todiscover the mutation(s) within TCF4 that segregate with disease
in families that show evidence of linkage to FCD2. l. Until such a
causative mutation(s) is identified, restraint needs to be exercised in
not drawing premature conclusions that a causal link between the
TCF4 protein and FECD has been identified.
Figure 1. Plot of the top multipoint linkage peak on chromosome 18. SNP markers are plotted along the x-axis by their deCODE map
position, and the LOD/HLOD scores for each marker are plotted along the y-axis. The results of the FASTLINK/HOMOG dominant two-point analysis
are indicated with black circles, and the results of the MERLIN dominant multipoint analysis are indicated with a black line. The SNP rs4941043 is the
peak marker from the two-point analysis (see Table 3). The location of the FCD2 peak (Sundin et al., 2006) and the most significantly associated SNP,
rs613872, from the FECD GWAS performed by Baratz et al. (2010) are indicated by arrows. The location of the TCF4 gene is also indicated for
reference. 2PT, two-point results; MPT, multipoint results; cM, centiMorgans; LOD, logarithm of the odds; HLOD, heterogeneity logarithm of the odds.
doi:10.1371/journal.pone.0018044.g001
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tissues, particularly in the corneal endothelium [29,42–46],
However, Tcf4 mutant mice do not appear to contain vision/eye
abnormalities as a phenotypic feature [47,48]. Additionally,
ENCODE data on the UCSC genome browser [49] (March 2006
assembly) shows that rs613872 is contained within the chromatin
immunoprecipitation sequence (ChIP-seq)-purported binding site
for two transcription factors, Ini1 (SMARCB1) and Brg1 (SMARCA4).
These are both components of the SWI/SNF chromatin remod-
eling complex that is required for transcriptional regulation of genes
normally repressed by chromatin [50,51]. Given that TCF4 is a
transcription factor, it is possible that variation at this site might
have an effect on the spatiotemporal expression of TCF4 and, in
turn, affect the expression of some of its targets. Further studies are
required to investigate the veracity this hypothesis.
Our study provides supporting evidence of a linkage signal to
the strong association results of rs613872. This not only further
confirms the importance of a locus on chromosome 18 in
influencing FECD risk, but also indicates that a causal variant
for FECD may be identified within this locus. It is highly possible
that rs613872 is tagging a rare variant within this locus that plays a
role in the etiology of FECD. Additional sequencing studies using
family datasets that are highly linked to this locus is a potential
strategy to identify the biological mechanisms underlying how this
locus influences FECD pathogenesis.
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